3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ingersoll Rand's board approved an amended employment agreement with Chairman and CEO Vicente Reynal that extends his initial term to February 29, 2032, raises his base salary from $1.1 million to $1.2 million, and adds a performance-based equity award. The filing also reports that Senior Vice President Michael Weatherred retired effective immediately, and that Scott Watson and Shaun Carlson were promoted to group president roles. For shareholders, the new CEO award vests only if Adjusted EPS grows at a compound annual rate of at least 8% to 10% over five years.
Reynal's base salary rises from $1.1 million to $1.2 million; target bonus stays at 150% of base salary
Expected grant on November 23, 2026 of 226,098 performance stock units, valued at about $17.1 million, vesting on Adjusted EPS CAGR of 8% (50%) to 10% (100%) over 2027-2031
Michael Weatherred retired effective immediately after notice on October 27, 2026, and will serve in an advisory role through May 2028
Scott Watson and Shaun Carlson named senior vice presidents and group presidents, both internal promotions reporting to Reynal
Cyngn Inc. told Nasdaq that its audit committee will fall to two members when director Karen Macleod's resignation takes effect, below Nasdaq's three-member requirement. The company expects until the earlier of its next annual meeting or November 3, 2027 to regain compliance by appointing a qualified independent director.
Macleod, Audit Committee Chair, will not stand for re-election at the November 3, 2026 Annual Meeting and resigns when the polls close
Nasdaq Listing Rule 5605(c)(2)(A) requires at least three audit committee members, including one financially sophisticated member
Cyngn expects a compliance deadline of the earlier of its next annual meeting or November 3, 2027
Macleod said her decision was not the result of any disagreement with the company
GridAI Technologies entered into Amendment No. 4, effective September 1, 2026, to its CFO consulting agreement with BPC Consulting Ltd., under which Anna Skowron serves as interim Chief Financial Officer. The amendment sets a fixed monthly retainer of $27,000 and grants up to 250,000 restricted stock units that vest over time, subject to continued service. Shareholders would bear these costs and potential share issuance, and the filing does not quantify the total value or dilution.
Fixed monthly retainer of $27,000 effective September 1, 2026, replacing the hourly rate and separate billing for hours above 30 per week.
Up to 250,000 RSUs, including 75,000 vesting September 1, 2026, and 25,000 each quarter-end from March 31, 2027 through December 31, 2027.
Agreement term runs through August 31, 2027, with automatic one-year renewals; the company may terminate on six months' notice.
Board may consider additional RSU grants to Ms. Skowron in calendar 2027 but is not obligated to do so.
On October 28, 2026, Omeros's Compensation Committee granted CEO Gregory A. Demopulos an option to buy up to 500,000 shares, vesting only if stock-price hurdles of $25.00 to $40.00 are met and he remains in service. The committee cited his 2025 achievements, including FDA approval of YARTEMLEA and the sale of zaltenibart to Novo, and said the award was set below peer-level long-term incentives. For shareholders, the award pays out only if the stock rises substantially, but any shares issued on exercise would dilute existing holders.
Option covers up to 500,000 shares of common stock, with an exercise price of $17.88, the October 28, 2026 closing price
Four tranches vest at 30-day volume-weighted average prices of $25.00, $30.00, $35.00 and $40.00, about 40%, 68%, 96% and 124% above the grant-date close
Time condition: 25% of each tranche becomes eligible one year after grant, with the remainder vesting in monthly installments over the following 36 months
LiveOne disclosed that Craig Christensen, its interim chief financial officer, interim treasurer, interim secretary and acting principal accounting officer, is leaving to pursue another professional opportunity, effective October 30, 2026. The company says the departure is not due to any dispute and that it has started a search for a successor, so finance leadership remains in interim roles for now.
Craig Christensen held interim CFO, interim treasurer, interim secretary and acting principal accounting officer roles.
He notified the company on October 26, 2026; departure is effective October 30, 2026.
The company states the exit is not the result of any dispute.
LiveOne has commenced a search for a qualified successor; no successor is named in the filing.
Utz Brands disclosed that CEO Howard Friedman will leave the company after the merger with Intersnack-linked buyers closes, with his employment expected to end November 30, 2026, and that he will leave the board at closing. The company also said board member B. John Lindeman received an offer to become CEO of Utz's post-closing operating company, subject to closing and a written employment agreement.
Friedman's employment is expected to end November 30, 2026, contingent on the merger closing; he leaves the board at closing
Friedman said his decision was not due to any disagreement with the company, Parent, or continuing stockholders
Lindeman received a letter agreement on October 29, 2026 offering the CEO role at Company LLC, with a contemplated start of November 30, 2026
Special meeting of stockholders is scheduled for November 13, 2026; two stockholder complaints were filed October 22, 2026, which the company says are without merit
Cable One expanded its board from eight to nine seats and elected Paul Keglevic, 72, as a director effective immediately. He was also named to a special committee evaluating strategic alternatives, which signals the board is working through a strategic review.
Board increased from eight to nine directors; Paul Keglevic, 72, elected effective October 30, 2026
Keglevic to receive a monthly cash fee of $40,000, plus $7,500 per diem for extra duties
Keglevic named to a special committee of the Board established to evaluate strategic alternatives
Previously CEO of Energy Future Holdings Corp. (2016-2018) and former audit partner at PricewaterhouseCoopers LLP
Proficient Auto Logistics appointed Steven Hansen, co-founder of Hansen & Adkins, to its Board of Directors effective October 30, 2026. The Board determined Mr. Hansen is not independent because of his business ties to the Company, including leases with entities he partly owns and the August 2026 acquisition of Hansen & Adkins, so he is not expected to join any Board committees.
Mr. Hansen will serve until the 2027 annual meeting and has agreed to waive Board compensation.
He owns a 50% equity interest in each of two lessors; the aggregate annual lease value is approximately $1.2 million with 3611 Farquhar Investments, LLC and approximately $180,000 with 480 Dick Buchanan Street, LLC.
His advisory employment agreement, dated August 14, 2026, provides compensation at a prorated annual rate of $250,000 through December 31, 2026.
The Company paid an upfront price of approximately $130 million for Hansen & Adkins, including about $75 million of assumed debt, and issued 421,354 shares to Mr. Hansen as part of the consideration.
Equity LifeStyle Properties said Patrick Waite will succeed Marguerite Nader as President and Chief executive officer effective January 1, 2027, and Waite will also join the Board. Nader will remain on the Board as Executive Vice Chair, and David Eldersveld will become Chief Operating Officer, as part of a multi-year succession plan. The filing reports no financial results or guidance changes.
Nader ceases to be Vice Chairman and CEO on December 31, 2026 and becomes Executive Vice Chair of the Board on January 1, 2027.
Waite, 60, becomes President and CEO on January 1, 2027 and is elected to the Board, which increases from nine to ten directors.
Waite's approved 2027 base salary is $614,935, with bonus potential of 290% of base salary; Eldersveld's is $476,558, with bonus potential of 220%.
The Board declared a fourth quarter 2026 dividend of $0.5425 per share, payable January 8, 2027 to holders of record on December 24, 2026.
LendingTree said General Counsel Heather Novitsky will leave the role effective December 31, 2026, and stay on as a non-executive employee providing transition services until her employment ends without cause on March 12, 2027. The company also adopted amended and restated bylaws effective October 27, 2026, mainly clarifying stockholder meeting, nomination and adjournment procedures.
Heather Novitsky's General Counsel role ends December 31, 2026; employment ends March 12, 2027
Compensation Committee approved Tier A severance under the Executive Severance Pay Plan, subject to a release of claims
Sixth Amended and Restated Bylaws took effect October 27, 2026, clarifying hybrid meetings, advance notice rules and Board postponement power
Verra Mobility said CFO Craig Conti will resign effective November 4, 2026. The Board appointed Matthew Kvarda, a Managing Director at Alvarez & Marsal, as interim CFO effective November 5, 2026, while a search firm assists in finding a permanent CFO. Kvarda's services are provided through an engagement with Alvarez & Marsal, which the company pays directly, and he will not receive compensation from Verra Mobility.
Craig Conti resigns as Executive Vice President and Chief Financial Officer effective November 4, 2026.
Matthew Kvarda, 56, is appointed interim CFO and principal financial officer effective November 5, 2026, until a permanent CFO is appointed.
Verra Mobility will pay Alvarez & Marsal $150,000 per month plus expenses, rising to $165,000 from May 1, 2027; fees through October 31, 2027 may not exceed $1,890,000 without consent.
Spencer Stuart is assisting the Board in the search for a permanent Chief Financial Officer.
Tempest Therapeutics said Chief Financial Officer Constance Ames resigned effective immediately on October 26, 2026, citing personal considerations unrelated to the company. The board appointed Stephanie Horn-Warnock as CFO, principal financial and accounting officer, treasurer and corporate secretary, also effective immediately, and she will work for the company as a consultant under an engagement letter dated October 28, 2026.
Constance Ames resigned as CFO and from all other company positions, effective immediately, for personal considerations unrelated to the company.
Stephanie Horn-Warnock, 37, was appointed CFO effective immediately on October 26, 2026.
Horn-Warnock previously was Vice President of Finance at ROM Technologies Inc. from January 2024 to September 2026.
Under her consulting engagement letter dated October 28, 2026, the company will pay $450 per hour plus expenses and an indirect cost allocation of 5.0% of total professional fees.
System1, Inc. said its President and Chief Operating Officer, Charles Ursini, resigned effective at the close of business on October 30, 2026. He will stay on the Board of Directors and serve as a strategic advisor to management, and the filing gives no replacement or financial details.
Charles Ursini resigned as President and Chief Operating Officer, effective close of business October 30, 2026
Ursini notified the company of the resignation on October 26, 2026
He had served as President and COO since April 2024
He will continue as a director and strategic advisor to management
NextCure said its Chief Medical Officer, Dr. Udayan Guha, will be terminated effective October 31, 2026, in connection with the pending merger with Avere Therapeutics, Inc. He signed a severance agreement and release, and additional change-in-control severance is payable only if the merger closes.
Dr. Udayan Guha, Chief Medical Officer and a named executive officer, is terminated effective October 31, 2026.
The departure is tied to the pending merger of NextCure and Avere Therapeutics, Inc.
Severance follows his existing employment agreement; enhanced change-in-control severance applies only if the merger closes.
The filing does not state the dollar amount of severance.
Gorman-Rupp's board approved the appointment of David J. Daniels Jr. as a newly created Chief Administrative Officer, effective January 4, 2027. He will oversee the company's Information Technology and Human Resources functions, workforce development plans and use of artificial intelligence, and currently serves as Group President of the Gorman-Rupp Pumps Group. The filing reports no compensation figures, and the role is an executive reorganization rather than a change in financial results.
Board approved the appointment on October 28, 2026; effective date is January 4, 2027
Daniels, age 50, has been Group President of the Gorman-Rupp Pumps Group since May 2021
Role covers IT, Human Resources, workforce development and artificial intelligence use
Company and Daniels will enter its standard Change of Control Severance and Indemnification Agreements
Genworth Financial said President and CEO Thomas J. McInerney will retire and leave its board effective December 31, 2026. Jerome T. Upton, the company's CFO, will become President and CEO and join the board effective January 1, 2027, and Angela R. Simmons will become Executive Vice President and CFO on the same date.
Thomas J. McInerney retires as President and CEO and resigns from the board effective December 31, 2026.
Jerome T. Upton, currently CFO, is to become President and CEO and a board member effective January 1, 2027.
Angela R. Simmons, currently CFO of the Closed Block, is to become Executive Vice President and CFO effective January 1, 2027.
The filing says McInerney's retirement is not the result of any disagreement with the company, and compensation terms for Upton and Simmons will be disclosed later by amendment.
Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board effective October 25, 2026, replacing Cheng Liu, Ph.D., who became Chief Scientific Officer while remaining President and a director. The filing also sets Pussinen's pay package, including a 1,000,000-share option grant and base salary increases tied to future financing, and says the Board adopted a plan to propose a change to its director class structure for stockholder vote in 2027.
Cynthia Pussinen, age 57, appointed CEO, Class I director and Board Chairperson effective October 25, 2026
Pussinen's base salary is $250,000, rising to $400,000, $450,000 and $525,000 as cumulative qualifying funding after October 25, 2026 exceeds $35.0 million, $55.0 million and $75.0 million
Option to purchase 1,000,000 shares granted on the second business day after the filing, with 25% vesting on October 25, 2027
Proposed amendment to Article V, Section A to be submitted to stockholders at the 2027 annual meeting
Shutterstock founder Jon Oringer returned as Chief Executive Officer and Chairman, effective October 28, 2026, replacing interim CEO Rik Powell, who remains Chief Financial Officer. Hichame Assi, CEO of the Company's Envato unit, was named President and Chief Operating Officer, and the company said it will not hold its scheduled third quarter 2026 earnings call on November 5, 2026, citing an ongoing review of its strategic direction.
Oringer's base salary rose from $1.00 to $1,000,000; he is not eligible for an annual cash bonus for the rest of fiscal 2026 or fiscal 2027
Assi's fixed pay is AUD 775,000 a year, with a target bonus of up to 60% from fiscal 2027, and RSU awards with a target value of $1.5 million
The company will not hold its previously scheduled third quarter 2026 earnings conference call on November 5, 2026
Southern Missouri Bancorp's Chief Financial Officer, Stefan Chkautovich, resigned effective November 7, 2026, to pursue another professional opportunity. The company's President and Chief Administrative Officer, Matthew T. Funke, a former CFO from 2006 to 2022, will become principal financial officer, and the filing says no new compensation arrangements were made for that role.
Chkautovich, CFO since August 31, 2023, informed the company and Southern Bank of his resignation on October 26, 2026, effective November 7, 2026.
Matthew T. Funke, President and Chief Administrative Officer, was appointed principal financial officer upon the resignation taking effect.
Funke and the company did not enter into, and do not anticipate, any compensatory arrangements for the appointment.
At the October 26, 2026 annual meeting, shareholders re-elected or elected directors Rebecca M. Brooks, David L. McClain and Mary Jane Judy to terms ending in 2029, approved the say-on-pay vote, and ratified FORVIS MAZARS, LLP as auditor fo
Summit Hotel Properties appointed Michael Nieves as Executive Vice President and Chief Financial Officer and promoted Adam Wudel to Executive Vice President and Chief Operating Officer, both effective November 1, 2026. Nieves most recently served as Senior Vice President of Finance and Treasurer at PENN Entertainment, and Wudel has been the Company's Executive Vice President of Corporate Development since 2024, so both changes put the Company's finance and operations leadership in new roles at the same time.
Michael Nieves becomes CFO effective November 1, 2026, with a $450,000 base salary and a time-based restricted stock award valued at $750,000.
Adam Wudel becomes COO effective November 1, 2026, with a $450,000 base salary; he has been with the Company since its 2011 IPO.
Both employment agreements run from November 1, 2026 to November 1, 2027, renewing automatically for one-year terms unless either party gives at least 30 days' notice.
PennyMac Financial reported third-quarter 2026 net income of $29 million, or $0.54 per diluted share, down from $182 million a year earlier, while total net revenues fell 26% to $469 million. The company also named Kevin Ryan as its next Chief Financial Officer effective January 1, 2027, succeeding Daniel Perotti, and amended employment agreements with Chairman and CEO David Spector and President Doug Jones. Management said fourth-quarter adjusted return on equity is expected to remain near current levels.
Q3 2026 net income was $29 million, or $0.54 diluted EPS, versus $182 million, or $3.37, in Q3 2025; total net revenues were $469 million, down 26% year over year.
Adjusted diluted EPS was $1.05, down from $1.39 in Q2 2026; production segment posted a $7 million pretax loss.
Kevin Ryan, currently Chief Strategy Officer, becomes CFO on January 1, 2027; Daniel Perotti resigns as CFO effective December 31, 2026 and moves to an advisory role.
Doug Jones, President and Chief Mortgage Banking Officer, is set to retire June 30, 2027; Spector's term runs through December 31, 2031.
Hormel Foods disclosed that John F. Ghingo's employment agreement, which was tied to his role as President and was set to expire December 31, 2026, terminated October 26, 2026 under an October 23, 2026 letter agreement, as he took on the additional role of Chief Executive Officer. The filing says Ghingo now has no specified term as President and CEO, which is a governance detail rather than a change in operations or financial results.
John F. Ghingo began serving as President and Chief Executive Officer effective October 26, 2026, and continues on the Board of Directors.
His prior Employment Agreement, scheduled to expire December 31, 2026, terminated as of October 26, 2026.
The Letter Agreement was entered into October 23, 2026; the filing states he has no specified term as President and CEO.
The full Letter Agreement is expected to be filed as an exhibit to the Form 10-K for the fiscal year ended October 25, 2026.
FGI Industries Ltd. said its board appointed Jennifer Earl as President and Chief Operating Officer, effective November 1, 2026. Earl has been President of FGI North America since January 2025, and her salary will rise to CAD $311,850 with continued participation in the company's incentive plans.
Appointment approved by the board on October 26, 2026, effective November 1, 2026
Earl previously served as President of FGI North America since January 2025 and as Executive Vice President, FGI Canada, from January 2022 to January 2025
Salary to increase to CAD $311,850; she continues in the Management Incentive Plan and Equity Incentive Plan
Aehr Test Systems expanded its board from six to seven seats and appointed Narsing Vijayrao as an independent director effective October 28, 2026. He also joins the Compensation Committee, a change that adds a director with long technology infrastructure and semiconductor experience to oversight of executive pay.
Board increased from six to seven authorized directors; appointment effective October 28, 2026
Vijayrao most recently was Vice President of Infrastructure at Meta Platforms, from April 2013 to August 2026
Non-employee pay: $65,000 annual cash retainer plus an initial RSU grant of $140,000 vesting over four years, then an annual $140,000 RSU grant
Serves until the next annual shareholder meeting; Board deemed him independent under Nasdaq standards
Justin Yorke resigned as chair of Processa's board on October 27, 2026, and the board appointed Dr. Sheila Gujrathi as non-employee Executive Chair on October 28, effective immediately; Yorke remains a board member. The October 29 press release also reported FDA clearance of an IND for a Phase 2 study of VT-7208 in chronic spontaneous urticaria and said cash is expected to fund operations into the second half of 2029.
Justin Yorke resigned as board chair on October 27, 2026 and remains a board member.
Dr. Sheila Gujrathi was appointed non-employee Executive Chair on October 28, 2026, effective immediately.
The FDA cleared the IND for a Phase 2 CSU study of VT-7208 planned to enroll approximately 120 adults.
The company expects its cash resources to support operations into the second half of 2029.
U.S. Bancorp said Vice Chair and Chief Risk Officer Jodi L. Richard resigned effective immediately to take a position at another publicly traded company, and that the resignation was not due to any disagreement with the company. Executive Vice President and Chief Credit Officer Troy W. Remington will serve as interim Chief Risk Officer while the company selects a successor.
Jodi L. Richard notified the company of her resignation on October 23, 2026, effective immediately
Resignation was not due to any disagreement with the company on operations, policies or practices
Troy W. Remington, Executive Vice President and Chief Credit Officer, is interim Chief Risk Officer
The company has not yet named a permanent successor
Hilton Grand Vacations said Executive Vice President and Chief Sales & Marketing Officer Dustin Tonkin will leave the company effective April 1, 2027, under a separation agreement. Mike Riley, a company veteran since 2012, was promoted to the same role effective October 29, 2026. The changes concern the leadership of the company's sales and marketing function, and the filing does not include financial results or guidance.
Dustin Tonkin, EVP and Chief Sales & Marketing Officer, separates from the company effective April 1, 2027.
Separation benefits include cash equal to two times his 2026 base salary and target short-term bonus, plus COBRA premiums for up to 18 months, subject to a release and restrictive covenants.
Mike Riley was promoted to EVP and Chief Sales & Marketing Officer effective October 29, 2026, after more than 25 years of industry experience, including 15 years with the company.
Tonkin's stock option exercise period was extended to 24 months from the separation date.
The Clorox Company's board appointed Fabian Garcia, currently president of Unilever Personal Care, as chief executive officer effective January 5, 2027. Linda Rendle steps down as CEO and chair on that date and will serve as a senior advisor through April 2, 2027, while Matthew Shattock becomes independent chair. The filing lists Garcia's offer terms, including a $100,000 base salary and an $11,000,000 sign-on RSU award, and the company's first-quarter fiscal 2027 earnings are scheduled for November 2.
Fabian Garcia appointed CEO effective January 5, 2027; he will also join the board
Linda Rendle steps down as CEO and director on January 5, 2027, and advises through April 2, 2027
Matthew Shattock to become independent chair, with a $225,000 chair retainer
Garcia's offer letter includes a $100,000 base salary, $2,000,000 target annual bonus and $11,000,000 one-time sign-on RSU award
Opendoor Technologies announced that Michael Alfred, founder and managing partner of Alpine Fox LP, joined its Board of Directors effective October 29, 2026, and also joined the Nominating and Corporate Governance Committee. The filing describes a board seat and standard director equity award, not a financial result or change in company guidance.
Alfred appointed as a Class I director with a term expiring at the 2027 annual meeting of stockholders.
Alfred was granted 45,268 restricted stock units, a prorated annual equity award that vests in full at the 2027 annual meeting.
The Board determined Alfred is independent under Nasdaq listing standards; he is also a current board member of IREN Limited and Bakkt Holdings, Inc.
Norwegian Cruise Line announced that Meghan Montana, currently Chief Strategy Officer, will become Executive Vice President and Chief Financial Officer on January 1, 2027, replacing Mark Kempa, who moves to a special advisor role through June 30, 2027. The filing sets out Montana's $875,000 base salary and Kempa's transition terms, which matter to shareholders because they mark a change in the leader of the company's finances.
Meghan Montana becomes CFO effective January 1, 2027; her base salary is $875,000 per year.
Mark A. Kempa remains CFO through December 31, 2026, then serves as Special Advisor to the CEO until his separation date of June 30, 2027.
Montana's sign-on bonus totals $1,550,000, with two $400,000 installments payable after March 1, 2027 and March 1, 2028.
Kempa will receive 33,000 time-based restricted share units in early January 2027 in lieu of a prorated 2027 bonus.
Coastal Financial said Brian Hamilton, president of its CCBX fintech and banking-as-a-service division, will step down as an employee and move to a consulting role, and that Chief Executive Eric M. Sprink voluntarily agreed to a lower base salary. The company said both changes are part of a broader cost-reduction and operational-efficiency effort, and the filing does not include financial results.
Brian Hamilton ceases as CCBX president and employee; he will remain a consultant and a board member
Hamilton's consulting period runs through May 1, 2027, at $35,000 per month, capped at $245,000 total
CEO Eric M. Sprink's base salary falls from $874,000 to $500,000, effective October 28, 2026
Forestar Group's Executive Chairman, Donald J. Tomnitz, will retire effective October 31, 2026, and CEO Anthony W. Oxley will also serve as Executive Chairman from November 1, 2026. Tomnitz will provide advisory services through September 30, 2028 under a monthly fee of $41,667, and the filing also adds director Stacey H. Dwyer and notes that Samuel R. Fuller will not stand for re-election in 2027.
Donald J. Tomnitz retires as Executive Chairman effective October 31, 2026; he had served in the role since October 2017
Anthony W. Oxley, President and CEO, becomes Executive Chairman effective November 1, 2026, a role designated by D.R. Horton, Inc.
Tomnitz's advisory agreement runs through September 30, 2028 at $41,667 per month, with his RSUs and PSUs continuing to vest
Stacey H. Dwyer joins the Board effective November 1, 2026, and Samuel R. Fuller will not be nominated for re-election at the 2027 Annual Meeting
Gain Therapeutics appointed Jeanette Weidner as Vice President, Finance, effective October 28, 2026, and she will also serve as principal financial officer and principal accounting officer. The filing sets out her employment terms, including a $275,000 base salary, a target bonus of 35% of salary, and an option for 130,000 shares, which matter to shareholders because they define the compensation and severance commitments the company is taking on.
Appointment effective October 28, 2026; appointed on October 22, 2026
Annual base salary of $275,000 with an initial target bonus of 35% of base salary
Option to purchase up to 130,000 shares under the 2022 Equity Incentive Plan, vesting over four years
Severance of six months' base salary, or twelve months' base salary plus other benefits if terminated within twelve months after a change of control
Radian Group's Board appointed Daniel Kobell as Senior Executive Vice President and Chief Financial Officer on October 28, 2026. Mr. Kobell had served as Interim Chief Financial Officer since February 12, 2026, so the change makes his role permanent and gives the company a confirmed finance chief.
Appointment date: October 28, 2026, by the Board of Directors
Azora Therapeutics, formerly Adial Pharmaceuticals, appointed Matthew Davidson, Ph.D. as President and Chief Executive Officer effective October 28, 2026, succeeding Cary J. Claiborne, whose employment was terminated. The board also appointed Celia Economides as Chief Financial Officer, succeeding Vinay Shah, and Julie Saiki, Ph.D. as Chief Strategy Officer. Stockholders approved increasing authorized common stock from 100,000,000 to 500,000,000 shares and the name change, with the new ticker AZR expected to begin trading October 29, 2026.
Matthew Davidson, Ph.D. appointed President and CEO effective October 28, 2026; Cary J. Claiborne's employment terminated, subject to a release for severance.
Celia Economides appointed CFO, succeeding Vinay Shah, whose employment was terminated effective October 28, 2026.
Authorized common stock increases from 100,000,000 to 500,000,000 shares; the amendment takes effect 12:01 AM Eastern on October 29, 2026.
Stockholders approved issuance of up to 23,561,896 shares on exercise of milestone pre-funded and incentive warrants, among other proposals.
JAB Acquisition Corp I entered into a Consulting Services Agreement with its sponsor, JAB Acquisition Sponsor I, LLC, effective retrospectively from June 1, 2026. The company pays the sponsor $14,000 a month for Chairman Joshua Jagid to serve as CEO and Jack Bressman to serve as CFO, and the audit committee approved the related-party arrangement, including prior payments and a waiver of $50,000 in administrative fees.
Monthly consulting fee of $14,000: $8,000 to Joshua Jagid and $6,000 to Jack Bressman, paid from funds outside the trust account
$70,000 already paid covers June through October 2026
Sponsor waived $50,000 in administrative services fees for June through October 2026; payments resume at sponsor's discretion on November 10, 2026
Effective October 29, 2026, Q2 Holdings named CFO Jonathan Price co-CEO alongside Matthew Flake, who remains president and chairman, and appointed Price to a board expanded from seven to eight members. Price will also keep the CFO role during the company's search for a new CFO, and his pay and severance terms were revised as part of the change.
Effective October 29, 2026, Price becomes co-CEO alongside Flake; the board increases from seven to eight members.
Price's annual base salary rises to $520,000, and he receives an RSU grant valued at $3 million vesting over four years.
Price remains chief financial officer during the search for a new CFO, with no date for that search given in the filing.
Severance is set at 200% of base salary plus a pro-rata bonus, or 250% as a lump sum if terminated within 60 days before to 24 months after a change in control.
ABM Industries disclosed that Executive Vice President and Chief Operating Officer Rene Jacobsen will voluntarily retire effective February 1, 2027. He will move to an Executive Advisor role from November 1, 2026 until his retirement date, so the operations chief role will change hands during that period.
Rene Jacobsen gave notice on October 28, 2026 of his voluntary retirement, effective February 1, 2027.
Jacobsen moves from Executive Vice President and Chief Operating Officer to Executive Advisor effective November 1, 2026.
The filing does not name a successor or state any financial figures related to the change.
Align Technology said Jennifer L. Davis, former CEO of Procter & Gamble's Global Healthcare business, will become President and CEO on December 31, 2026, replacing Joseph M. Hogan, who has led the company since 2015 and will retire from the role and become a strategic advisor. Davis joins the Board as a director on November 2, 2026, and the filing sets out her pay package, including a $1,300,000 base salary and a $2,000,000 signing bonus. The change marks a planned leadership transition at the company, and the filing discloses no changes to financial results or guidance.
Jennifer L. Davis joins as CEO-elect and director on November 2, 2026, and becomes President and CEO on December 31, 2026
Joseph M. Hogan, CEO since 2015, retires as CEO on December 31, 2026 and will serve as a strategic advisor under a one-year consulting agreement with a $150,000 annual fee
Davis's pay includes a $1,300,000 base salary, a 150% target bonus, equity awards of $9,900,000 and $6,600,000, and a $2,000,000 signing bonus
Board size increases from ten to eleven directors effective November 2, 2026
Citizens & Northern Corporation said its board appointed director Aaron Singer as vice chair effective immediately, at an October 22, 2026 meeting. Chair Terry Lehman will step down at the 2027 annual shareholder meeting, when Singer is set to succeed him as chair, and Lehman intends to remain a director subject to nomination and election. The filing describes this as a planned leadership transition and does not include financial results or guidance.
Aaron Singer appointed Vice Chair of the Board effective immediately, per the October 22, 2026 board meeting
Terry Lehman to step down as Chair effective at the 2027 annual shareholder meeting; Singer to succeed him as Chair
Lehman intends to continue as a director, subject to Board nomination and shareholder election at the 2027 Annual Meeting
Singer has served on the Board since 2017 and chairs the Governance and Nominating Committee
T-Mobile US said Vice Chair G. Michael Sievert notified the Board on October 26, 2026, that he will resign from the Board and its Transaction Committee effective November 1, 2026, and will also stop serving as Vice Chair. The company said the timing matches the expiration of a September 19, 2025 amendment to his employment agreement, and that the resignation involves no disagreement over operations, policies or practices.
Resignation from the Board and Transaction Committee effective November 1, 2026
Notice to the Board given October 26, 2026
Timing tied to expiration of the September 19, 2025 amendment to his employment agreement
Company states the resignation is not due to any disagreement on operations, policies or practices
AIB Data Centers appointed Jason Burnett as Chief Operations Officer, effective October 26, 2026, after the Board approved the appointment on October 23, 2026. He will oversee construction execution, procurement and data center operations, and he reports directly to CEO Jerry Tang. His pay includes a base salary that rises with site financings and bonuses tied to delivering data center sites to customers, so shareholders will see how these costs scale as projects advance.
Board appointed Jason K. Burnett as Chief Operations Officer on October 23, 2026, effective October 26, 2026; he previously served as Chief Operating Officer of Hivelocity from 2024 to 2026.
Base salary of $250,000, rising to $300,000 upon closing of financing for the CLT1 site and to $350,000 upon closing of financing for the next site.
Site delivery bonuses are paid in three stages (25%, 25% and 50%) for each site delivered to a customer, covering the first ten sites to reach customer handoff.
The Company also entered into indemnification agreements with all current directors and executive officers on October 26, 2026.
Enanta Pharmaceuticals said CEO Jay R. Luly, Ph.D., 70, will retire by February 1, 2027, after 23 years leading the company, and will serve as a strategic advisor for the rest of 2027. The board has started a search for a successor, considering both internal and external candidates, and named Tara L. Kieffer, Ph.D., to the newly created role of Chief Operating Officer. The filing does not include financial results, so the changes are mainly about management succession for shareholders.
Jay R. Luly, Ph.D., age 70, will retire as President and CEO by February 1, 2027, after 23 years with the company
Luly will continue as a strategic advisor for the remainder of 2027; the company expects to enter an agreement for this role
The board is searching for a successor, considering internal and external candidates
Tara L. Kieffer, Ph.D., age 48, was appointed Chief Operating Officer on October 28, 2026; she joined Enanta in 2020 as Chief Product Strategy Officer
Parsons Corporation (NYSE: PSN) said CFO Matt Ofilos will resign effective November 6, 2026, to pursue another professional opportunity, and that his resignation is not due to a disagreement with the company. The board appointed George Ball, a former CFO and current director, as interim CFO on the same date while it searches for a permanent successor.
Matt Ofilos resigns as CFO effective November 6, 2026; the filing says there was no disagreement on operations, policies or practices.
George Ball, CFO from 2008 to 2022 and a board member since 2022, was appointed interim CFO on October 26, 2026, effective November 6, 2026.
Ball will receive a $2.4 million restricted stock unit award that vests on the one-year anniversary, pro-rated for his actual interim service period.
The same-day third-quarter 2026 earnings release reaffirmed the fiscal 2026 revenue and adjusted EBITDA guidance midpoints and narrowed the ranges.
Red Robin directors James C. Pappas and Christopher Martin resigned from the board and all committees, effective October 23, 2026, and the company said the resignations were not related to any disagreement over operations, policies or practices. The company plans to cut the board from eight to six directors, five of whom will be independent, and says the departures follow its refranchising program and a new $115 million credit facility.
Pappas (JCP Investment Management) and Martin (Jumana Capital) resigned effective October 23, 2026.
Board size will decrease from eight to six directors, five of whom will be independent.
New five-year, $115 million senior secured credit facility, led by JPMorgan Chase Bank, N.A., includes a $90 million term loan and a $25 million revolving credit facility.
Pappas and Martin joined the board in December 2024 in connection with an additional investment by Jumana and JCP.
Spero Therapeutics announced that Chief Operating Officer Timothy Keutzer will retire effective December 31, 2026, after 11 years with the company. He is expected to serve as a consultant through approximately February 28, 2027 to support the leadership transition.
Timothy Keutzer, Chief Operating Officer, retires effective December 31, 2026
Consulting arrangement expected to run until approximately February 28, 2027, terminable by either party on fifteen days' written notice
Keutzer will be paid an hourly rate during the consulting period; the filing gives no dollar figure
Enerpac Tool Group amended the offer letter of President and CEO Paul Sternlieb, setting out how his equity and cash incentives would be treated if he retires after a specified date, with a retirement date no earlier than July 31, 2030. The amendment also raises his change-in-control and severance benefits, which the company says is meant to keep him in the role and support a leadership transition.
Amendment dated October 26, 2026 sets a retirement notice period of 180 days, with windows starting in February 2030.
Severance multiples rise to 2 times base salary and annual incentive from 1.5 times; welfare premium coverage rises to 24 months from 18 months.
Legal fee reimbursement limits rise to $50,000 from $10,000 for enforcing severance terms, plus up to $50,000 for negotiating the amendment.
The amendment does not change Mr. Sternlieb's base salary, target bonus, or annual long-term equity award opportunity.
Fortune Brands Innovations, Inc. announced several leadership changes, including Executive Vice President and Chief Operating Officer Dave Barry's move to lead the Moen business and the hiring of Peter DuBois as Chief Information Officer. The company said the changes are meant to give its businesses more focus and speed up execution, and the filing gives no financial figures for the changes.
Dave Barry moves from Executive Vice President and Chief Operating Officer to Executive Vice President and President, Moen; the company determined this on October 22, 2026
Peter DuBois joins as Executive Vice President and Chief Information Officer effective November 2, 2026, reporting to CEO Jesse Singh; he previously was Chief Digital and Technology Officer of Serta Simmons Bedding
John D. Lee moves to Executive Vice President and Chief Innovation Officer effective November 2, 2026, and will focus on R&D and Consumer Services
Rachel Roberts becomes Chief Commercial Officer for Moen; Matt Zimmer, General Manager of House of Rohl since June 2026, will report directly to Singh
Cardiff Oncology said its Chief Medical Officer, Roger Sidhu, separated from the company on October 22, 2026, in a mutually agreed transition. The company appointed Dr. Leila Alland as interim Chief Medical Officer under a consulting agreement, and it also increased its authorized common stock to 300,000,000 shares. The filing does not include financial results or guidance.
Roger Sidhu separated from the company as Chief Medical Officer on October 22, 2026, in a mutually agreed transition.
Dr. Leila Alland's consulting agreement began October 23, 2026, and runs until April 22, 2027, or earlier if all services are completed.
Dr. Alland will be paid a monthly fee of $35,000 and will devote up to 50% of her professional time to the role.
Authorized common stock was increased to 300,000,000 shares, effective October 22, 2026.
CooperCompanies said Albert G. White III stepped down as President, Chief Executive Officer and director on October 27, 2026, and independent director Walter M. Rosebrough, Jr. was named interim Executive Chair. The press release said the company's recent performance has not met expectations, and the company reaffirmed its fiscal 2026 guidance. Shareholders face a leadership change while a permanent CEO is sought, and the board is changing composition with Shlomo Nachman joining in December 2026 and three directors not seeking reelection.
Albert G. White III resigned as President, CEO and director effective October 27, 2026, and will remain a strategic advisor through April 1, 2027.
Walter M. Rosebrough, Jr. was appointed interim Executive Chair effective immediately; a CEO Search Committee of Lawrence E. Kurzius, Cynthia L. Lucchese and Teresa S. Madden will oversee the CEO search.
Shlomo Nachman will join the board effective December 8, 2026; Barbara Carbone, Colleen E. Jay and Robert S. Weiss will not stand for reelection at the 2027 Annual Meeting.
The company reaffirmed its fiscal 2026 guidance provided on September 9, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.